HCV-mediated apoptosis of hepatocytes in culture and viral pathogenesis

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Silberstein, Erica ^a   Ulitzky, Laura ^a   Lima, Livia Alves ^a,c   Cehan, Nicoleta ^a,d   Teixeira Carvalho, Andréa ^a,e   Roingeard, Philippe ^b   Taylor, Deborah R ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITÉ DE TOURS   (France)

^c FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^d Southeastern Regional Laboratory   (United States)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2 INTERACTING KILLER PROTEIN; CASPASE; CASPASE 3; FAS ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN;

APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL SURFACE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; GENE EXPRESSION; HEPATITIS C VIRUS SUBTYPE 1B; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; VIRUS PATHOGENESIS; HEPACIVIRUS; HEPATITIS C; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOGENICITY; PATHOLOGY; TUMOR CELL CULTURE; VIROLOGY;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84976303528     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155708     Document Type: Article

References (53)

1. Bartenschlager R, Penin F, Lohmann V, Andre P. Assembly of infectious hepatitis C virus particles. Trends Microbiol 2011 Feb; 19(2):95-103. doi: 10.1016/j.tim.2010.11.005 PMID: 21146993
2. Poenisch M, Bartenschlager R. New insights into structure and replication of the hepatitis C virus and clinical implications. Semin Liver Dis 2010 Nov; 30(4):333-47. doi: 10.1055/s-0030-1267535 PMID: 20960374
3. Bartenschlager R, Cosset FL, Lohmann V. Hepatitis C virus replication cycle. J Hepatol 2010 Sep; 53(3):583-5. doi: 10.1016/j.jhep.2010.04.015 PMID: 20579761
4. Mengshol JA, Golden-Mason L, Rosen HR. Mechanisms of Disease: HCV-induced liver injury. Nat Clin Pract Gastroenterol Hepatol 2007 Nov; 4(11):622-34. PMID: 17978819
5. Kuiken C, Simmonds P. Nomenclature and numbering of the hepatitis C virus. Methods Mol Biol 2009; 510:33-53. doi: 10.1007/978-1-59745-394-3-4 PMID: 19009252
6. Murray CL, Rice CM. Turning hepatitis C into a real virus. Annual review of microbiology 2011; 65:307-27. doi: 10.1146/annurev-micro-090110-102954 PMID: 21682640
7. Lee MH, Yang HI, Lu SN, Jen CL, You SL, Wang LY, et al. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma. Int J Cancer 2014 Sep 1; 135(5):1119-26. doi: 10.1002/ijc.28753 PMID: 24482200
8. Joka D, Wahl K, Moeller S, Schlue J, Vaske B, Bahr MJ, et al. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. Hepatology 2012 Feb; 55(2):455-64. doi: 10.1002/hep.24734 PMID: 21993925
9. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005 Sep; 5(9):558-67. PMID: 16122679
10. Bartenschlager R, Sparacio S. Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture. Virus Res 2007 Aug; 127(2):195-207. PMID: 17428568
11. Pearlman BL. Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care. Lancet Infect Dis 2012 Sep; 12(9):717-28. doi: 10.1016/S1473-3099(12)70060-9 PMID: 22647717
12. Roingeard P. Hepatitis C virus diversity and hepatic steatosis. J Viral Hepat 2013 Feb; 20(2):77-84. doi: 10.1111/jvh.12035 PMID: 23301542
13. Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014 Aug 28; 20(32):11033-53. doi: 10.3748/wjg.v20.i32.11033 PMID: 25170193
14. Heim MH. Innate immunity and HCV. J Hepatol 2013 Mar; 58(3):564-74. doi: 10.1016/j.jhep.2012.10.005 PMID: 23063572
15. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000 Feb 15; 132(4):296-305. PMID: 10681285
16. Wang Y, Li J, Chen J, Liu L, Peng Z, Ding J, et al. From cirrhosis to hepatocellular carcinoma in HCV-infected patients: genes involved in tumor progression. Eur Rev Med Pharmacol Sci 2012 Aug; 16(8):995-1000. PMID: 22913147
17. Thimme R, Binder M, Bartenschlager R. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection. FEMS Microbiol Rev 2012 May; 36(3):663-83. doi: 10.1111/j.1574-6976.2011.00319.x PMID: 22142141
18. Ahmad W, Ijaz B, Hassan S. Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray. J Transl Med 2012; 10:41. doi: 10.1186/1479-5876-10-41 PMID: 22397681
19. Aizaki H, Harada T, Otsuka M, Seki N, Matsuda M, Li YW, et al. Expression profiling of liver cell lines expressing entire or parts of hepatitis C virus open reading frame. Hepatology 2002 Dec; 36(6):1431-8. PMID: 12447869
20. Basu A, Meyer K, Lai KK, Saito K, Di Bisceglie AM, Grosso LE, et al. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology 2006 Jun 5; 349(2):347-58. PMID: 16545852
21. Ciccaglione AR, Marcantonio C, Tritarelli E, Tataseo P, Ferraris A, Bruni R, et al. Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones. BMC Genomics 2008; 9:309. doi: 10.1186/1471-2164-9-309 PMID: 18590516
22. Nishimura-Sakurai Y, Sakamoto N, Mogushi K, Nagaie S, Nakagawa M, Itsui Y, et al. Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells. J Gastroenterol 2010 May; 45(5):523-36. doi: 10.1007/s00535-009-0162-3 PMID: 20012654
23. Walters KA, Syder AJ, Lederer SL, Diamond DL, Paeper B, Rice CM, et al. Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes. PLoS Pathog 2009 Jan; 5(1):e1000269. doi: 10.1371/journal.ppat.1000269 PMID: 19148281
24. Blackham S, Baillie A, Al-Hababi F, Remlinger K, You S, Hamatake R, et al. Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus. J Virol 2010 May; 84(10):5404-14. doi: 10.1128/JVI.02529-09 PMID: 20200238
25. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007 Jun; 35(4):495-516. PMID: 17562483
26. Bantel H, Schulze-Osthoff K. Apoptosis in hepatitis C virus infection. Cell Death Differ 2003 Jan; 10 Suppl 1:S48-S58. PMID: 12655346
27. Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev 2010 Jul; 90(3):1165-94. doi: 10.1152/physrev.00061.2009 PMID: 20664081
28. Silberstein E, Mihalik K, Ulitzky L, Plant EP, Puig M, Gagneten S, et al. Persistent growth of a human plasma-derived hepatitis C virus genotype 1b isolate in cell culture. PLoS Pathog 2010 May; 6(5): e1000910. doi: 10.1371/journal.ppat.1000910 PMID: 20502631
29. Reed LJ, Muench H. A simple method of estimating fifty percent end points. Am J Hyg 27: 493-497. Am J Hyg 1938;27:493-7.
30. Guo QL, Lin SS, You QD, Gu HY, Yu J, Zhao L, et al. Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells. Life Sci 2006 Feb 9; 78(11):1238-45. PMID: 16257012
31. Duan D, Zhang B, Yao J, Liu Y, Sun J, Ge C, et al. Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase. Free Radic Biol Med 2014 Apr; 69:15-25. doi: 10.1016/j.freeradbiomed.2013.12.027 PMID: 24407164
32. Zekri AR, Haleem HA, Esmat GE, Bahnassy AA, El-Din HM, Hafez MM, et al. Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4. J Viral Hepat 2007 Jul; 14(7):468-77. PMID: 17576388
33. Fischer R, Baumert T, Blum HE. Hepatitis C virus infection and apoptosis. World J Gastroenterol 2007 Sep 28; 13(36):4865-72. PMID: 17828818
34. Zekri AR, Bahnassy AA, Hafez MM, Hassan ZK, Kamel M, Loutfy SA, et al. Characterization of chronic HCV infection-induced apoptosis. Comparative hepatology 2011; 10(1):4. doi: 10.1186/1476-5926-10-4 PMID: 21781333
35. Ame JC, Spenlehauer C, de MG. The PARP superfamily. Bioessays 2004 Aug; 26(8):882-93. PMID: 15273990
36. Schreiber V, Dantzer F, Ame JC, de MG. Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 2006 Jul; 7(7):517-28. PMID: 16829982
37. Fan TJ, Han LH, Cong RS, Liang J. Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai) 2005 Nov; 37(11):719-27.
38. Harwood SM, Yaqoob MM, Allen DA. Caspase and calpain function in cell death: bridging the gap between apoptosis and necrosis. Ann Clin Biochem 2005 Nov; 42(Pt 6):415-31. PMID: 16259792
39. Ma YB, Chang HY. Caspase work model during pathogen infection. Virol Sin 2011 Dec; 26(6):366-75. doi: 10.1007/s12250-011-3218-5 PMID: 22160936
40. Gogela NA, Lin MV, Wisocky JL, Chung RT. Enhancing our understanding of current therapies for hepatitis C virus (HCV). Curr HIV/AIDS Rep 2015 Mar; 12(1):68-78. doi: 10.1007/s11904-014-0243-7 PMID: 25761432
41. Ghavami S, Hashemi M, Kadkhoda K, Alavian SM, Bay GH, Los M. Apoptosis in liver diseases - detection and therapeutic applications. Med Sci Monit 2005 Nov; 11(11):RA337-RA345. PMID: 16258409
42. Bantel H, Lugering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 2004 Nov; 40(5):1078-87. PMID: 15486927
43. Deng L, Adachi T, Kitayama K, Bungyoku Y, Kitazawa S, Ishido S, et al. Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J Virol 2008 Nov; 82(21):10375-85. doi: 10.1128/JVI.00395-08 PMID: 18768989
44. Zhao P, Han T, Guo JJ, Zhu SL, Wang J, Ao F, et al. HCV NS4B induces apoptosis through the mitochondrial death pathway. Virus Res 2012 Apr 19.
45. Ferraris P, Beaumont E, Uzbekov R, Brand D, Gaillard J, Blanchard E, et al. Sequential biogenesis of host cell membrane rearrangements induced by hepatitis C virus infection. Cell Mol Life Sci 2013 Apr; 70(7):1297-306. doi: 10.1007/s00018-012-1213-0 PMID: 23184194
46. Ferraris P, Blanchard E, Roingeard P. Ultrastructural and biochemical analyses of hepatitis C virus-associated host cell membranes. J Gen Virol 2010 Sep; 91(Pt 9):2230-7. doi: 10.1099/vir.0.022186-0 PMID: 20484561
47. Roingeard P, Hourioux C, Blanchard E, Prensier G. Hepatitis C virus budding at lipid droplet-associated ER membrane visualized by 3D electron microscopy. Histochem Cell Biol 2008 Sep; 130(3):561-6. doi: 10.1007/s00418-008-0447-2 PMID: 18512067
48. Sir D, Chen WL, Choi J, Wakita T, Yen TS, Ou JH. Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response. Hepatology 2008 Oct; 48(4):1054-61. doi: 10.1002/hep.22464 PMID: 18688877
49. Ait-Goughoulte M, Kanda T, Meyer K, Ryerse JS, Ray RB, Ray R. Hepatitis C virus genotype 1a growth and induction of autophagy. J Virol 2008 Mar; 82(5):2241-9. PMID: 18077704
50. Dreux M, Gastaminza P, Wieland SF, Chisari FV. The autophagy machinery is required to initiate hepatitis C virus replication. Proc Natl Acad Sci U S A 2009 Aug 18; 106(33):14046-51. doi: 10.1073/pnas.0907344106 PMID: 19666601
51. Chu VC, Bhattacharya S, Nomoto A, Lin J, Zaidi SK, Oberley TD, et al. Persistent expression of hepatitis C virus non-structural proteins leads to increased autophagy and mitochondrial injury in human hepatoma cells. PLoS One 2011; 6(12):e28551. doi: 10.1371/journal.pone.0028551 PMID: 22164304
52. Aweya JJ, Sze CW, Bayega A, Mohd-Ismail NK, Deng L, Hotta H, et al. NS5B induces up-regulation of the BH3-only protein, BIK, essential for the hepatitis C virus RNA replication and viral release. Virology 2015 Jan 1; 474:41-51. doi: 10.1016/j.virol.2014.10.027 PMID: 25463603
53. El-Bassiouni A, Nosseir M, Zoheiry M, El-Ahwany E, Ghali A, El-Bassiouni N. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma. APMIS 2006 Jun; 114(6):420-7. PMID: 16856963